Search research articles
Contact Us
Filters
Showing results (51-60 of 87) with videos related to
Page
of 9
Sort By:
Annals of Translational Medicine
|
August 29, 2022
Correlation between cholecystectomy and development of non-alcoholic liver disease in the mouse model
Hye Young Kim, Sung Ryol Lee, Waqar Khalid Saeed, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 4, 2022
Central Nervous System Delivery of the Catalytic Subunit of DNA-Dependent Protein Kinase Inhibitor Peposertib as Radiosensitizer for Brain Metastases
Surabhi Talele, Wenjuan Zhang, Ju-Hee Oh, et al.
Frontiers in Immunology
|
June 25, 2026
Versatile electroporation protocols enable reproducible CRISPR-RNP delivery across multiple primary mouse cells of the hematopoietic lineage
Ju Hee Oh, Lucy F Yang, Erin Tanaka, et al.
Nutrients
|
April 13, 2024
Ticagrelor, but Not Clopidogrel, Attenuates Hepatic Steatosis in a Model of Metabolic Dysfunction-Associated Steatotic Liver Disease
Eun Jeoung Lee, Seung Min Lee, Ju Hee Oh, et al.
Molecular Pharmaceutics
|
January 17, 2025
PEGylation Improves the Therapeutic Index of Dexamethasone To Treat Acute Respiratory Distress Syndrome with Obesity Background in Mouse
Xian Wu, Hong Guo, Xiangxiang Hu, et al.
Oncotarget
|
October 22, 2016
Suppression of gain-of-function mutant p53 with metabolic inhibitors reduces tumor growth in vivo
Chae Lim Jung, Hyemin Mun, Se-Young Jo, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 12, 2023
Central Nervous System Distribution of Panobinostat in Preclinical Models to Guide Dosing for Pediatric Brain Tumors
Wenqiu Zhang, Ju-Hee Oh, Wenjuan Zhang, et al.
Life (Basel, Switzerland)
|
November 11, 2022
Regulation of Hepatocyte Nuclear Factor 4α Attenuated Lipotoxicity but Increased Bile Acid Toxicity in Non-Alcoholic Fatty Liver Disease
Yoon Jin Roh, Yun Kim, Jae Sun Lee, et al.
Journal of Chromatographic Science
|
December 20, 2018
Optimized liquid chromatography-tandem mass spectrometry for Otaplimastat quantification in rat plasma and brain tissue
Seolhee Lee, Miri Kim, Ju-Hee Oh, et al.
Journal of Gastroenterology and Hepatology
|
May 28, 2019
Decrease in fat de novo synthesis and chemokine ligand expression in non-alcoholic fatty liver disease caused by inhibition of mixed lineage kinase domain-like pseudokinase
Waqar Khalid Saeed, Dae Won Jun, Kiseok Jang, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 87) with videos related to
Sort By:
Page
of 9
Annals of Translational Medicine
|
August 29, 2022
Correlation between cholecystectomy and development of non-alcoholic liver disease in the mouse model
Hye Young Kim, Sung Ryol Lee, Waqar Khalid Saeed, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 4, 2022
Central Nervous System Delivery of the Catalytic Subunit of DNA-Dependent Protein Kinase Inhibitor Peposertib as Radiosensitizer for Brain Metastases
Surabhi Talele, Wenjuan Zhang, Ju-Hee Oh, et al.
Frontiers in Immunology
|
June 25, 2026
Versatile electroporation protocols enable reproducible CRISPR-RNP delivery across multiple primary mouse cells of the hematopoietic lineage
Ju Hee Oh, Lucy F Yang, Erin Tanaka, et al.
Nutrients
|
April 13, 2024
Ticagrelor, but Not Clopidogrel, Attenuates Hepatic Steatosis in a Model of Metabolic Dysfunction-Associated Steatotic Liver Disease
Eun Jeoung Lee, Seung Min Lee, Ju Hee Oh, et al.
Molecular Pharmaceutics
|
January 17, 2025
PEGylation Improves the Therapeutic Index of Dexamethasone To Treat Acute Respiratory Distress Syndrome with Obesity Background in Mouse
Xian Wu, Hong Guo, Xiangxiang Hu, et al.
Oncotarget
|
October 22, 2016
Suppression of gain-of-function mutant p53 with metabolic inhibitors reduces tumor growth in vivo
Chae Lim Jung, Hyemin Mun, Se-Young Jo, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 12, 2023
Central Nervous System Distribution of Panobinostat in Preclinical Models to Guide Dosing for Pediatric Brain Tumors
Wenqiu Zhang, Ju-Hee Oh, Wenjuan Zhang, et al.
Life (Basel, Switzerland)
|
November 11, 2022
Regulation of Hepatocyte Nuclear Factor 4α Attenuated Lipotoxicity but Increased Bile Acid Toxicity in Non-Alcoholic Fatty Liver Disease
Yoon Jin Roh, Yun Kim, Jae Sun Lee, et al.
Journal of Chromatographic Science
|
December 20, 2018
Optimized liquid chromatography-tandem mass spectrometry for Otaplimastat quantification in rat plasma and brain tissue
Seolhee Lee, Miri Kim, Ju-Hee Oh, et al.
Journal of Gastroenterology and Hepatology
|
May 28, 2019
Decrease in fat de novo synthesis and chemokine ligand expression in non-alcoholic fatty liver disease caused by inhibition of mixed lineage kinase domain-like pseudokinase
Waqar Khalid Saeed, Dae Won Jun, Kiseok Jang, et al.
Page
of 9